GleamWall
中文EN

CHE CHEMED CORP

Services-Home Health Care Services · NYSE · SEC CIK 19584 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY5.2%
TTM net income YoY1.3%
TTM EPS YoY10.5%
Revenue 3-yr CAGR6.1%
Net income 3-yr CAGR4.9%

Margins

Gross margin33.6%
Operating margin13.9%
Net margin10.6%
FCF margin11.1%
EBITDA margin16.3%

Returns

ROE29.1%
ROA16.9%
ROIC (approx.)27.4%
Asset turnover1.59x

Leverage & solvency

Liabilities / assets49.9%
Debt / equity0.27x
Current ratio1.11x
Interest coverage75.39x

Cash quality & payout

Operating cash flow / net income1.29x
Accruals ratio-4.8%
Payout ratio11.9%
Capex / revenue2.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$690.94M$673.25M$657.51M$639.34M$624.90M$618.80M$646.94M$639.99M
Cost of revenue$457.98M$451.78M$441.75M$414.17M$425.14M$434.11M$430.53M$405.88M
Gross profit$232.96M$221.47M$215.76M$225.17M$199.76M$184.69M$216.41M$234.12M
SG&A expense$111.47M$115.20M$114.32M$105.50M$105.78M$100.32M$105.59M$104.25M
Operating income$96.42M$89.20M$84.58M$100.65M$74.75M$68.08M$94.76M$113.88M
Interest expense$2.10M$1.79M$512,000$521,000$457,000$443,000$329,000$499,000
Pretax income$96.71M$91.33M$88.84M$105.44M$83.54M$71.11M$95.67M$120.12M
Income tax$25.06M$23.63M$22.54M$28.69M$19.31M$18.62M$23.92M$29.80M
Net income$71.65M$67.70M$66.30M$76.75M$64.24M$52.49M$71.76M$90.32M
EBITDA$110.85M$103.47M$101.45M$116.98M$88.41M$81.77M$110.78M$129.71M
EPS (basic)5.495.144.85—4.463.604.91—
EPS (diluted)5.455.134.84—4.463.574.86—
Dividends declared per share0.700.600.600.600.600.500.500.50
Weighted avg. shares (diluted)13.13M13.20M13.69M—14.41M14.70M14.76M—
Balance sheet
Cash & equivalents$48.43M$40.22M$16.86M$74.52M$129.75M$249.90M$173.88M$178.35M
Receivables$254.86M$188.63M$215.48M$182.57M$215.57M$184.88M$285.87M$171.16M
Inventory$7.75M$7.63M$7.21M$7.54M$8.24M$9.15M$7.79M$8.19M
Current assets$365.73M$291.24M$274.06M$302.62M$395.24M$491.38M$502.38M$394.75M
PP&E, net$216.96M$208.50M$207.73M$205.66M$203.94M$202.28M$199.68M$200.84M
Goodwill$754.76M$667.00M$667.00M$667.00M$666.99M$667.00M$666.94M$666.74M
Intangibles$78.79M$78.60M$80.42M$82.76M$84.93M$87.36M$89.93M$92.21M
Total assets$1.72B$1.58B$1.54B$1.54B$1.62B$1.72B$1.73B$1.67B
Current liabilities$330.93M$319.85M$321.42M$287.13M$292.04M$263.89M$290.56M$285.69M
Long-term debt$236.00M$140.00M$91.20M—————
Total debt$236.00M$140.00M$91.20M—————
Total liabilities$857.02M$749.08M$687.82M$558.78M$546.94M$519.36M$544.75M$549.58M
Shareholders' equity$861.42M$830.51M$847.99M$979.40M$1.08B$1.20B$1.18B$1.12B
Net debt$187.57M$99.78M$74.34M—————
Cash flow statement
Operating cash flow$56.59M$84.81M$88.22M$133.53M$83.39M$138.61M$32.74M$164.91M
Capital expenditure$18.72M$15.52M$17.12M$16.35M$17.50M$15.81M$13.28M$12.76M
Free cash flow$37.87M$69.29M$71.10M$117.19M$65.89M$122.80M$19.46M$152.15M
Investing cash flow-$81.39M-$28.24M-$37.79M-$15.95M-$14.23M-$15.48M-$13.67M-$12.52M
Financing cash flow$33.01M-$33.21M-$108.09M-$172.82M-$189.31M-$47.10M-$23.54M-$212.49M
Depreciation & amortization$14.43M$14.27M$16.87M$16.33M$13.66M$13.69M$16.02M$15.83M
Dividends paid$9.19M$7.88M$8.17M$8.50M$8.65M$7.22M$7.33M$7.50M
Share buybacks$62.52M$97.48M$190.04M$174.56M$180.78M$42.95M$33.22M$209.34M

Free plan shows the latest 8 periods; Pro shows all 70 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.